Ronaxan Vet. 20 mg tabletter til hund og katt
Ronaxan Vet. 20 mg tabletter til hund og katt
Authorised
- Doxycycline hyclate
Product identification
Medicine name:
Ronaxan Vet. 20 mg tabletter til hund og katt
Active substance:
- Doxycycline hyclate
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Doxycycline hyclate20.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Norway
Available in:
-
Norway
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Denmark A/S
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Norwegian Medical Products Agency
Authorisation number:
- 00-08085
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 27/06/2023
Updated on: 28/06/2023
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 27/06/2023
Updated on: 28/06/2023
How useful was this page?: